Barclays
GCTK icon

Barclays’s GlucoTrack GCTK Stock Holding History

Barclays’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$402 Buy
+84
New +$790 ﹤0.01% 5038
2025
Q3 		– Sell
-50
Closed -$4.51K – 5573
2025
Q2 		$4.51K Buy
+50
New +$6.59K ﹤0.01% 4985

Other funds holding GCTK

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
GIPW
Granite Islands Private Wealth Guilford, Connecticut $135M AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Barclays's GCTK Position: Q2 2026 in Review

Barclays opened a new position in GlucoTrack (GCTK) in Q2 2026: 84 shares worth $402. The stake represents ﹤0.01% of the portfolio and ranks #5038 among its holdings. This is a return to the name: Barclays previously reported a position in GCTK as recently as Q2 2025.

Barclays first reported a position in GCTK in Q2 2025 and has held it in 2 quarters since. The position peaked at $4.51K in Q2 2025. 18 funds tracked by Wall St. Rank hold GCTK as of Q2 2026.

  • Barclays held 84 shares of GlucoTrack worth $402 as of Q2 2026.
  • GlucoTrack was a new Barclays position in Q2 2026.
  • GlucoTrack made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5038 holding.
  • Barclays first reported a position in GlucoTrack in Q2 2025 and has held it in 2 quarters since.
  • Barclays's GlucoTrack position peaked at $4.51K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.